Concord Wealth Partners Ionis Pharmaceuticals Inc Transaction History

Concord Wealth Partners

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$37.12 - $46.52 $1,336 - $1,674	36 New	36 $1,000
Q2 2022 Aug 04, 2022	SELL	$31.71 - $43.0 $2,251 - $3,053	-71 Reduced 46.41%	82 $3,000
Q1 2022 Apr 20, 2022	SELL	$29.88 - $37.04 $8,964 - $11,112	-300 Reduced 66.23%	153 $6,000
Q4 2021 Jan 21, 2022	BUY	$25.61 - $35.1 $8,604 - $11,793	336 Added 287.18%	453 $14,000
Q3 2021 Nov 09, 2021	SELL	$33.54 - $40.55 $10,062 - $12,165	-300 Reduced 71.94%	117 $4,000
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $4,973 - $7,462	117 Added 39.0%	417 $19,000
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $13,590 - $18,081	300 New	300 $17,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

Stay updated on Concord Wealth Partners with notifications on news.